Ovidiu Veresezan

Influence of age and self-stigmatization on social eating and drinking issues in French outpatients living with and beyond head and neck cancer: a mixed-method study

Bérengère Beauplet, Bianca Francois, Vianney Bastit, Justine Lequesne et autres

fr, lu, gb (code pays fourni par la source)

Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients

Arthur Daban, Ludivine Beaussire-Trouvay, Émilie Lévêque, Cristina Alexandru et autres

BACKGROUND: Liquid biopsy application is still challenging in glioblastoma patients and the usefulness of short-length DNA (slDNA) fragments is not established. The aim was to investigate slDNA concentration as a prognostic marker in unresected glioblastoma patients. METHODS: Patients with unresected glioblastoma and …

fr (code pays fourni par la source)

Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline

Nicolas Martz, Julia Salleron, F. Dhermain, Guillaume Vogin et autres

PURPOSE: Radiotherapy is, with surgery, one of the main therapeutic treatment strategies for meningiomas. No prospective study has defined a consensus for the delineation of target volumes for meningioma radiotherapy. Therefore, target volume definition is mainly based on information from retrospective studies …

fr, lu, us, be (code pays fourni par la source)

Prospective evaluation of factors associated with acceptance of feeding tube (FT) placement and clinical outcomes during radiation therapy (RT) or radiochemotherapy (RTCT) for head and neck squamous cell carcinoma (HNSCC).

Florian Clatot, Sorina Mihailescu, M. Ebran, Olivier Rigal et autres

12103 Background: RT/RTCT during HNSCC treatment is associated with a high rate of severe dysphagia requiring the use of a FT. Randomized trials have failed to show a benefit of a prophylactic enteral nutrition in case of RTCT. Even when indicated, numerous …

fr (code pays fourni par la source)

Short-length DNA fragments in plasma to predict clinical outcome in unresected glioblastoma patients.

Maxime Fontanilles, Arthur Daban, Ludivine Beaussire, Émilie Lévêque et autres

2025 Background: Early prediction of therapeutic response is an important issue in glioblastoma patients. Cell-free DNA (cfDNA) concentration in plasma shown potential prognostic value. cfDNA release is influenced by non-tumor parameters. Short-length cfDNA (slDNA) may better reflect tumor evolution. The aim was …

fr (code pays fourni par la source)

PD-0653 Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline.

Nicolas Martz, J. Salleron, F. Dhermain, Guillaume Vogin et autres

Characterization of positioning uncertainties in PET‐CT‐MR trimodality solutions for radiotherapy

Pauline Hinault, Isabelle Gardin, Pierrick Gouel, Pierre Decazes et autres

The purpose of this study was to evaluate the positioning uncertainties of two PET/CT-MR imaging setups, C1 and C2. Because the PET/CT data were acquired on the same hybrid device with automatic image registration, experiments were conducted using CT-MRI data. In C1, …

fr (code pays fourni par la source)

Prospective Evaluation of Sarcopenia in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy

S. Thureau, L. Lebret, Justine Lequesne, Marine Cabourg et autres

Highlights: Sarcopenia is frequent in patients treated with radiation therapy (RT) or radiochemotherapy (RTCT) for head and neck squamous cell carcinomas. Sarcopenia is associated with poor disease-free survival and overall survival outcomes. Sarcopenia is not associated with a higher rate of treatment-related …

fr (code pays fourni par la source)

Trimodality PET/CT/MRI and Radiotherapy: A Mini-Review

Pierre Decazes, Pauline Hinault, Ovidiu Veresezan, S. Thureau et autres

Computed tomography (CT) has revolutionized external radiotherapy by making it possible to visualize and segment the tumors and the organs at risk in a three-dimensional way. However, if CT is a now a standard, it presents some limitations, notably concerning tumor characterization …

fr (code pays fourni par la source)

PH-0039: Impact of sarcopenia on survival and recurrence after radiotherapy for head and neck cancer

S. Thureau, L. Lebret, S. Dandoy, M. Ebran et autres

Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol

Jennifer Le Guévelou, Colin Debaigt, Esma Saâda-Bouzid, Julien Viotti et autres

INTRODUCTION: Up to 50% of soft tissue sarcoma (STS) patients develop metastases in the course of their disease. Cytotoxic therapy is a standard treatment in this setting but yields average tumour response rates of 25% at first line and ≤10% at later …

fr (code pays fourni par la source)

Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial

Yungan Tao, Anne Aupérin, Pierre Blanchard, M. Alfonsi et autres

BACKGROUND: Concurrent chemoradiotherapy (CRT) is the standard of care (SoC) in locally advanced (LA) head and neck squamous cell carcinomas (HNSCC). This trial was designed to test whether dose-escalated IMRT and cisplatin could improve locoregional control without increasing complications over 3D-radiotherapy. METHODS: …

fr, ch (code pays fourni par la source)